Retail marijuana sales projected to decline despite cannabis legalization gains

Retail cannabis sales in mature markets decline despite legalization gains as oversupply and price compression squeeze operators, offsetting growth in emerging states.

Objective Facts

U.S. regulated cannabis revenues for 2025 marked the first-ever annual year-over-year decline for the legal cannabis market, falling below the $30.1 billion level achieved in 2024. Whitney Economics projects the U.S. legal cannabis market will reach $30.5 billion in 2026, up 4.9% from 2025, though the firm notes cannabis is entering a more mature, less forgiving phase where price compression is defining the market itself. More mature markets are experiencing double-digit decreases in sales, including Arizona, Illinois, Maine, Maryland, and Oklahoma. Wholesale cannabis prices have declined in major markets over the past two years, particularly in mature markets such as California, Oregon, and Colorado, where increased supply and competition have impacted overall sales performance. While total consumer demand remains resilient, shopping habits have evolved toward budget optimization, with customers visiting more frequently but with more surgical intent, leading to a rise in micro-transactions.

Left-Leaning Perspective

Progressive and legalization-advocacy outlets have focused on the equity and criminal justice dimensions of cannabis policy rather than retail sales dynamics. Governor Kathy Hochul announced a $17 million investment to expand Social and Economic Equity initiatives and programming, noting that since market launch New York's cannabis market has generated $3.3 billion in total retail sales and expanded to more than 600 licensed dispensaries statewide. NORML's analysis emphasizes that marijuana use by young people has fallen dramatically during the past decade overlapping with adoption of state-level cannabis regulations, with marijuana use by teens falling 25 percent among 12th graders, 45 percent among 10th graders, and 38 percent among 8th graders since 2012. Regarding retail sales challenges, NORML contends most states impose taxes on cannabis products that far surpass those imposed upon other goods, including alcohol, and in many cases excessive taxes steer consumers toward the unregulated market where they can purchase marijuana at far cheaper prices. Left-leaning coverage emphasizes that legalization is delivering on promised criminal justice and equity goals, while retail challenges reflect market maturation rather than fundamental failures of legalization policy.

Right-Leaning Perspective

Conservative and libertarian outlets have diverged sharply on cannabis retail decline, with some criticizing the New York Times' calls for higher taxation while others, particularly from the public health right, support the Times' concerns about high-potency products. Reason magazine's Jacob Tuccille argues the New York Times' tax-based approach is inherently paternalistic and questions whether it would help legalization work, noting that such policies would compound disadvantages that licensed pot suppliers face in competing with untaxed and unregulated dealers. NORML Deputy Director Paul Armentano, while not conservative, has framed the critique of taxation in libertarian terms: excessive taxation doesn't discourage consumers from obtaining cannabis but rather steers them to the unregulated market. On the other side, Fox News reported on the New York Times' reversal on legalization, with the Times warning that daily cannabis use has surged and calling for restrictions on high-potency cannabis, recommending making illegal any marijuana product exceeding 60% THC and imposing higher taxes on potent forms. The conservative-libertarian divide on cannabis reflects deeper disagreements about the proper role of taxation and regulation in mature markets.

Deep Dive

Retail cannabis sales are declining in mature markets like California, Colorado, Oregon, and Washington despite broader state legalization, representing a fundamental shift from the explosive growth phase of 2020-2021. Whitney Economics projects 2026 growth of 4.9% nationwide, but frames this as masking a deeper transition: cannabis is entering a more mature, less forgiving phase where price compression—not rapid expansion—is defining market dynamics. The core mechanism is straightforward: wholesale cannabis prices have declined due to increased supply, expanding cultivation capacity, and growing competition, particularly in mature markets such as California, Oregon, and Colorado, where increased supply and competition have impacted overall sales performance. The disagreement about why this matters centers on taxation and regulation. NORML and libertarian analysts argue that excessive taxation doesn't discourage consumers from obtaining cannabis but rather steers them to the unregulated market, and that to disrupt the illicit cannabis market, state-licensed retailers must offer competitive pricing. Industry analysts note the impact is most severe in competitive, mature markets where pricing pressure is highest, with retailers facing the largest mismatch between profits and taxes, even as consumer demand remains strong. Conversely, the New York Times reversed its long-standing support for marijuana legalization in 2026, warning daily use has surged and calling for restrictions on high-potency cannabis, recommending making illegal any marijuana product exceeding 60% THC and imposing higher taxes. What each side overlooks: progressive framing focuses on equity and youth protection data while understating pricing pressures that force operators into unregulated-market competition; conservative public health concerns cite genuine risks of high-potency products but understate evidence that youth use has actually declined since legalization. Both miss that retail sales decline in mature markets may be inevitable market maturation—the result of supply-demand equilibrium after a pandemic-era boom, not a failure of legalization policy itself.

OBJ SPEAKING

Create StoryTimelinesVoter ToolsRegional AnalysisPolicy GuideAll StoriesCommunity PicksUSWorldPoliticsBusinessHealthEntertainmentTechnologyAbout

Retail marijuana sales projected to decline despite cannabis legalization gains

Retail cannabis sales in mature markets decline despite legalization gains as oversupply and price compression squeeze operators, offsetting growth in emerging states.

May 14, 2026
What's Going On

U.S. regulated cannabis revenues for 2025 marked the first-ever annual year-over-year decline for the legal cannabis market, falling below the $30.1 billion level achieved in 2024. Whitney Economics projects the U.S. legal cannabis market will reach $30.5 billion in 2026, up 4.9% from 2025, though the firm notes cannabis is entering a more mature, less forgiving phase where price compression is defining the market itself. More mature markets are experiencing double-digit decreases in sales, including Arizona, Illinois, Maine, Maryland, and Oklahoma. Wholesale cannabis prices have declined in major markets over the past two years, particularly in mature markets such as California, Oregon, and Colorado, where increased supply and competition have impacted overall sales performance. While total consumer demand remains resilient, shopping habits have evolved toward budget optimization, with customers visiting more frequently but with more surgical intent, leading to a rise in micro-transactions.

Left says: Progressive officials frame cannabis legalization as advancing equity, safety, and opportunity, with New York's approach demonstrating that growth and equity are not mutually exclusive while aggressively shutting down illicit shops that threaten public safety.
Right says: NORML argues excessive taxation doesn't discourage consumers from obtaining cannabis but rather steers them to the unregulated market, and to disrupt the illicit cannabis market and permit legal markets to thrive, state-licensed retailers must offer competitive pricing, which few currently can.
✓ Common Ground
Some observers across the spectrum acknowledge Whitney Economics' data showing 24 states posted cannabis revenue declines compared with just 15 seeing gains in 2025, and that this is not a story about a rising tide lifting all boats but rather an industry with far less room for error.
Multiple sources, including industry analysts and academic researchers, agree that price disparities stem from oversupply in mature markets, limited retail access in emerging states, and policy frameworks that restrict interstate commerce, with cannabis prices continuing to decline due to oversupply and regulatory constraints.
Both progressive and libertarian advocates acknowledge that since 2021, average retail cannabis prices have dropped 32% due to overproduction and increased competition, viewing this as positive for consumers though challenging for operators.
Objective Deep Dive

Retail cannabis sales are declining in mature markets like California, Colorado, Oregon, and Washington despite broader state legalization, representing a fundamental shift from the explosive growth phase of 2020-2021. Whitney Economics projects 2026 growth of 4.9% nationwide, but frames this as masking a deeper transition: cannabis is entering a more mature, less forgiving phase where price compression—not rapid expansion—is defining market dynamics. The core mechanism is straightforward: wholesale cannabis prices have declined due to increased supply, expanding cultivation capacity, and growing competition, particularly in mature markets such as California, Oregon, and Colorado, where increased supply and competition have impacted overall sales performance.

The disagreement about why this matters centers on taxation and regulation. NORML and libertarian analysts argue that excessive taxation doesn't discourage consumers from obtaining cannabis but rather steers them to the unregulated market, and that to disrupt the illicit cannabis market, state-licensed retailers must offer competitive pricing. Industry analysts note the impact is most severe in competitive, mature markets where pricing pressure is highest, with retailers facing the largest mismatch between profits and taxes, even as consumer demand remains strong. Conversely, the New York Times reversed its long-standing support for marijuana legalization in 2026, warning daily use has surged and calling for restrictions on high-potency cannabis, recommending making illegal any marijuana product exceeding 60% THC and imposing higher taxes. What each side overlooks: progressive framing focuses on equity and youth protection data while understating pricing pressures that force operators into unregulated-market competition; conservative public health concerns cite genuine risks of high-potency products but understate evidence that youth use has actually declined since legalization. Both miss that retail sales decline in mature markets may be inevitable market maturation—the result of supply-demand equilibrium after a pandemic-era boom, not a failure of legalization policy itself.

◈ Tone Comparison

Progressive outlets emphasize equity, criminal justice remedies, and the success of redirecting consumers from illicit to legal markets, using framing like "delivering real results" and highlighting youth protection. Conservative and libertarian voices—particularly around taxation—employ skepticism about government intervention, using phrases like "this does not sound like a formula for making legalization work" and criticizing paternalistic policy-making, while some conservative voices emphasizing public health concerns use alarmist language about addiction and psychosis.